Ani Pharmaceuticals (ANIP) Preferred Dividend Payments (2012 - 2025)
Ani Pharmaceuticals (ANIP) posted Preferred Dividend Payments of $344000.0 for Q3 2025, down 15.48% sequentially from $407000.0 in Q2 2025, and down 15.27% YoY from $406000.0 in Q3 2024.
Ani Pharmaceuticals (ANIP) Preferred Dividend Payments (2012 - 2025) Analysis & Trends
Ani Pharmaceuticals has reported Preferred Dividend Payments for 7 years, with the latest figure at $344000.0 in Q3 2025.
- Quarterly Preferred Dividend Payments fell 15.27% year-over-year to $344000.0 in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $751000.0 (down 53.78% YoY) and the FY2025 annual result came in at $1.2 million, down 28.8% from the prior year.
- Preferred Dividend Payments slipped to $344000.0 in Q3 2025 per ANIP's latest filing, from $407000.0 in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $407000.0 in Q2 2022 and troughed at $190000.0 in Q4 2021.
- A 5-year average of $388875.0 and a median of $406000.0 in 2022 frame the typical range for Preferred Dividend Payments.
- The sharpest annual moves came in 2022 and 2025: Preferred Dividend Payments jumped 114.21% in 2022, then dropped 15.27% in 2025.
- Over 5 years, Preferred Dividend Payments stood at $190000.0 in 2021, then soared by 114.21% to $407000.0 in 2022, then dropped by 0.25% to $406000.0 in 2023, then changed by 0.0% to $406000.0 in 2024, then slipped by 15.27% to $344000.0 in 2025.
- According to Business Quant data, Preferred Dividend Payments over the past three periods registered $344000.0, $407000.0, and $406000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 344,000.00 |
| Jun 30, 2025 | 407,000.00 |
| Mar 31, 2025 | 406,000.00 |
| Dec 31, 2024 | 406,000.00 |
| Sep 30, 2024 | 406,000.00 |
| Jun 30, 2024 | 407,000.00 |
| Mar 31, 2024 | 406,000.00 |
| Dec 31, 2023 | 406,000.00 |
| Sep 30, 2023 | 406,000.00 |
| Jun 30, 2023 | 407,000.00 |
| Mar 31, 2023 | 406,000.00 |
| Dec 31, 2022 | 407,000.00 |
| Sep 30, 2022 | 406,000.00 |
| Jun 30, 2022 | 407,000.00 |
| Mar 31, 2022 | 405,000.00 |
| Dec 31, 2021 | 190,000.00 |
| Dec 31, 2013 | 1,000.00 |
| Jun 30, 2013 | 2.37 Mn |
| Mar 31, 2013 | 2.60 Mn |
| Dec 31, 2012 | 2.60 Mn |